ProStocks Logo
Unlimited Trades ₹899 Monthly
www.ProStocks.com
Contact us

Accretion Pharmaceuticals IPO vs Safecure IPO

Comparison between Accretion Pharmaceuticals IPO and Safecure IPO.

IPO Details

Accretion Pharmaceuticals IPO is a SME Fixed Price IPO proposed to list at NSE SME while Safecure IPO is a SME Fixed Price proposed to list at BSE SME.

 Accretion Pharmaceuticals IPOSafecure IPO
LogoAccretion Pharmaceuticals IPO LogoSafecure IPO Logo
Issue CategorySMESME
Issue TypeIPOIPO
Process TypeBookbuildingFixed Price
Listing AtNSE SMEBSE SME
Lead ManagersJawa Capital Services Pvt.Ltd.Sun Capital Advisory Services Pvt.Ltd.
RegistrarKfin Technologies Ltd.MUFG Intime India Pvt.Ltd.
Market MakerGretex Share Broking Pvt.Ltd.Giriraj Stock Broking Pvt.Ltd.
DRHPDRHP DRHP
RHPRHP
Final ProspectusFinal Prospectus Final Prospectus
Anchor InvestorAnchor Investor
IPO Allotment URLIPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Accretion Pharmaceuticals IPO is up to ₹28.26 Cr whereas the issue size of the Safecure IPO is up to ₹29.07 Cr. The final issue price of Accretion Pharmaceuticals IPO is ₹101.00 per share and of Safecure IPO is ₹102.00 per share.

 Accretion Pharmaceuticals IPOSafecure IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹96.00 per share
Issue Price (Upper)₹101.00 per share
Issue Price (Final)₹101.00 per share₹102.00 per share
Discount (Retail)₹0.00 per share
Discount (Employee)
Market Lot Size1200 shares1200 shares
Fresh Issue Size27,98,400 shares28,50,000 shares
Fresh Issue Size (Amount)up to ₹28.26 Crup to ₹29.07 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total27,98,400 shares28,50,000 shares
Issue Size Total (Amount)up to ₹28.26 Crup to ₹29.07 Cr

IPO Timetable

Accretion Pharmaceuticals IPO opens on May 14, 2025, while Safecure IPO opens on Oct 29, 2025. The closing date of Accretion Pharmaceuticals IPO and Safecure IPO is May 16, 2025, and Oct 31, 2025, respectively.

 Accretion Pharmaceuticals IPOSafecure IPO
Anchor Bid DateMay 13, 2025
Issue OpenMay 14, 2025Oct 29, 2025
Issue CloseMay 16, 2025Oct 31, 2025
Basis Of Allotment (Tentative)May 19, 2025Nov 03, 2025
Initiation of Refunds (Tentative)May 20, 2025Nov 04, 2025
Credit of Share (Tentative)May 20, 2025Nov 04, 2025
Listing date (Tentative)May 21, 2025Nov 06, 2025
Anchor Lockin End date 1Jun 18, 2025
Anchor Lockin End date 2Aug 17, 2025

Financials & KPIs

Accretion Pharmaceuticals IPO P/E ratio is 21.29, as compared to Safecure IPO P/E ratio of 11.66.

 Accretion Pharmaceuticals IPOSafecure IPO
Financials

Company Financials (Restated Consolidated)

Period Ended31 Dec 202431 Mar 202431 Mar 202331 Mar 2022
Assets39.9927.0520.5817.74
Total Income35.7533.9429.5322.58
Profit After Tax5.243.880.100.08
NET Worth13.585.353.843.08
Reserves and Surplus5.411.35
Total Borrowing13.7913.488.477.61
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended30 Jun 202531 Mar 202531 Mar 202431 Mar 2023
Assets54.6153.0737.4830.94
Total Income18.3673.2763.0647.74
Profit After Tax1.996.165.693.98
EBITDA12.4311.369.09
NET Worth22.9420.9315.009.33
Reserves and Surplus16.1714.168.127.62
Total Borrowing19.5220.5514.3011.51
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)10094.33
Promoter Shareholding (Post-Issue)73.4866.14
P/E Ratio21.2911.66
Market Cap₹112.27 Cr.₹102.41 Cr.
ROE72.4728.86
ROCE36.7322.48
Debt/Equity2.520.98
EPS₹4.74₹8.75
RoNW72.4728.86

Shares Offered

In the Accretion Pharmaceuticals IPO Retail Individual Investors (RII) are offered 12,22,800 shares while in Safecure IPO retail investors are offered 12,22,800 shares. Qualified Institutional Buyers (QIB) are offered 1,41,600 shares in Accretion Pharmaceuticals IPO and 0 shares in Safecure IPO.

 Accretion Pharmaceuticals IPOSafecure IPO
Anchor Investor Reservation2,11,200 shares0 shares
Market Maker Reservation1,47,600 shares1,50,000 shares
QIB1,41,600 shares0 shares
NII12,22,800 shares14,24,400 shares
RII12,22,800 shares14,25,600 shares
Employee0 shares0 shares
Others
Total27,98,400 shares28,50,000 shares

Bids Received (Subscription)

Accretion Pharmaceuticals IPO subscribed 7.09x in total, whereas Safecure IPO subscribed 1.81x.

 Accretion Pharmaceuticals IPOSafecure IPO
QIB (times)12.14x
NII (times)4.28x0.32x
Big NII (times)
Small NII (times)
RII (times)10.54x3.31x
Employee (times)
Other (times)
Total (times)7.09x1.81x

Compare with others

Accretion Pharmaceuticals IPOSafecure IPO
Patil Automation IPOAccretion Pharmaceuticals IPO
Sharvaya Metals IPOSuriFresh Extract IPO
Moving Media Entertainment IPOIndicosmic Infotech IPO
B.D.Industries IPOJinsuri Electromet IPO
Connplex Cinemas IPODivine Hira Jewellers IPO
SuriFresh Extract IPOPatel Chem Specialities IPO
Indicosmic Infotech IPOParadeep Parivahan IPO
Jinsuri Electromet IPOManoj Jewellers IPO
Divine Hira Jewellers IPOShree Refrigerations IPO
Safecure IPORama Telecom IPO

Compare:

Accretion Pharmaceuticals IPO Vs Safecure IPO